MP
Mumtaz Pothaparambath
About Mumtaz Pothaparambath
Data last updated:
Mumtaz Pothaparambath is a Director at Orient Drugs Private Limited (since 1997). The company operates in Pharma. Orient Drugs Private Limited reported revenue of ₹7.95 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Orient Drugs Private Limited U24231KL1997PTC011301 | Director | 01 Sep 1997 | 1997 | ₹7.95 Cr (FY 2025) | Active |
Board colleagues of Mumtaz Pothaparambath
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abdu Avulan | 01827943 | Orient Drugs Private Limited | Managing Director |
| Fathima Sheikmoossa Avulan | 07460057 | Orient Drugs Private Limited | Director |
| Favas Avulan | 06759875 | Orient Drugs Private Limited | Director |
| Jameela Konndla Badiuzzaman | 07460071 | Orient Drugs Private Limited | Director |
| Naseer Kalappaden | 01827936 | Orient Drugs Private Limited | Director |
| Shibibiyya Mecheri | 09568099 | Orient Drugs Private Limited | Director |
| Ummer Thekkepath | 07463474 | Orient Drugs Private Limited | Director |
| Zubairali Valiyathodi | 07460101 | Orient Drugs Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mumtaz Pothaparambath
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mumtaz Pothaparambath
Mumtaz Pothaparambath currently holds 1 directorship: Orient Drugs Private Limited (Director, since 01 Sep 1997, revenue ₹7.95 Cr (FY 2025)).
Mumtaz Pothaparambath was first appointed on 01 Sep 1997 as Director at Orient Drugs Private Limited.
The current boards of Mumtaz Pothaparambath's companies include Abdu Avulan (Orient Drugs Private Limited), Fathima Sheikmoossa Avulan (Orient Drugs Private Limited), Favas Avulan (Orient Drugs Private Limited), Jameela Konndla Badiuzzaman (Orient Drugs Private Limited), Naseer Kalappaden (Orient Drugs Private Limited), Shibibiyya Mecheri (Orient Drugs Private Limited), among others.